Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
Study First Submitted
Endpoints
Primary
Proportion of patients with sarcopenia at different stages of rehabilitation after cardiac surgery as assessed by EWGSOP2-criteria
Timeframe: 1 to 4 times (baseline, 4 weeks after surgery, 16 weeks after surgery, 1-year after surgery) during the follow-up period, depending on the cohort the patient is in.
Screening for the presence of sarcopenia by the SARC-F questionnaire
Timeframe: 1 to 4 times (baseline, 4 weeks after surgery, 16 weeks after surgery, 1-year after surgery) during the follow-up period, depending on the cohort the patient is in.
Handgrip strength assessed with a handheld dynamometer
Timeframe: 1 to 4 times (baseline, 4 weeks after surgery, 16 weeks after surgery, 1-year after surgery) during the follow-up period, depending on the cohort the patient is in.
Lower body strength assessed by the 5x sit-to-stand test
Timeframe: 1 to 4 times (baseline, 4 weeks after surgery, 16 weeks after surgery, 1-year after surgery) during the follow-up period, depending on the cohort the patient is in.
Muscle quantity assessed by bio-electrical impedance (InBody 770s)
Timeframe: 1 to 4 times (baseline, 4 weeks after surgery, 16 weeks after surgery, 1-year after surgery) during the follow-up period, depending on the cohort the patient is in.
Severity of sarcopenia assessed by short physical performance battery
Timeframe: 1 to 4 times (baseline, 4 weeks after surgery, 16 weeks after surgery, 1-year after surgery) during the follow-up period, depending on the cohort the patient is in.
Severity of sarcopenia assessed by 4m walking speed
Timeframe: 1 to 4 times (baseline, 4 weeks after surgery, 16 weeks after surgery, 1-year after surgery) during the follow-up period, depending on the cohort the patient is in.
Severity of sarcopenia assessed by timed up-and-go test
Timeframe: 1 to 4 times (baseline, 4 weeks after surgery, 16 weeks after surgery, 1-year after surgery) during the follow-up period, depending on the cohort the patient is in.
Secondary (9)
Medical history assessed from the patient medical record
Medication assessed from the patient medical record
Blood sampling assessed from the patient medical record
Anthropometrics
Demographics assessed by anamnesis
Show 4 moreShow less
Physical activity level as assessed by the IPAQ-SF
Diet and nutritional status as assessed by the MEDAS and MNA questionnaires
Quality of life as assessed by the SF-36 questionnaire
Anxiety and depression assessed by the HADS questionnaire
Arms and interventions
Cardiac rehabilitation in UZ Leuven
This cohort contains patients who will follow cardiac rehabilitation in UZ Leuven and will be followed-up at 4 weeks (start of CR), 16 weeks (end of CR) and 1 year after their cardiac surgery
Cardiac rehabilitation not in UZ Leuven
This cohort contains patients who will follow cardiac rehabilitation elsewhere and will be followed-up at 1 year after their cardiac surgery
No cardiac rehabilitation
These patients will not follow any formal phase II ambulatory cardiac rehabilitation program. They might follow some physiotherapy sessions in a private practice. Depending on sarcopenia status at the end of their hospital stay they will be followed after 1 year (if no sarcopenia present) or after 4 weeks, 16 weeks, and 1 year (if sarcopenia present)
Baseline data only
These patients consent with the baseline testing during their hospitalization after cardiac surgery and also with the use of their data to answer our first research question (What is the prevalence of sarcopenia after cardiac surgery?), but explicitly indicated that they would not partake in any further testing, independent of the presence of sarcopenia or the location of their rehabilitation